Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Park, Keunchil

Class:Id	Person:9713883
_displayName	Park, Keunchil
_timestamp	2021-02-02 01:30:15
created	[InstanceEdit:9713889] Rothfels, Karen, 2021-02-02
firstname	Keunchil
initial	K
surname	Park
(author)	[LiteratureReference:9713886] Efficacy and Safety of Lorlatinib in Korean Non-Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase Inhibitor [LiteratureReference:9713948] Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatment [LiteratureReference:9913580] KRAS^G12C Inhibition with Sotorasib in Advanced Solid Tumors
[Change default viewing format]

No pathways have been reviewed or authored by Park, Keunchil (9713883)